FDA Inspection
Pharmadax (Foshan) Co., Ltd.Pharmadax (Foshan) Co., Ltd. – FDA Inspection, Sep 23, 2016
Record Details
This FDA Inspection record concerns Pharmadax (Foshan) Co., Ltd., with an inspection on September 23, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Pharmadax (Foshan) Co., Ltd.
- Inspection Date
- September 23, 2016
- Product Type
- Drugs
View Company Profile
ID · 21b9a6a2-70ad-49ab-a38e-29c1119ef5b3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 989069
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.160(b)Scientifically sound laboratory controls
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Pharmadax (Foshan) Co., Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| December 7, 2024 | Not classified | Office of Inspections and Investigations | |
| September 12, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 25, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Pharmadax (Foshan) Co., Ltd.
- FDA Inspection 1258271 - 2024-12-07
- FDA Inspection 1105491 - 2019-09-12
- FDA Inspection 843627 - 2013-07-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.